Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.

Journal of Cardiovascular Translational Research
Clint L Miller, Chen Yan

Abstract

The second messengers, cAMP and cGMP, regulate a number of physiological processes in the myocardium, from acute contraction/relaxation to chronic gene expression and cardiac structural remodeling. Emerging evidence suggests that multiple spatiotemporally distinct pools of cyclic nucleotides can discriminate specific cellular functions from a given cyclic nucleotide-mediated signal. Cyclic nucleotide phosphodiesterases (PDEs), by hydrolyzing intracellular cyclic AMP and/or cyclic GMP, control the amplitude, duration, and compartmentation of cyclic nucleotide signaling. To date, more than 60 different isoforms have been described and grouped into 11 broad families (PDE1-PDE11) based on differences in their structure, kinetic and regulatory properties, as well as sensitivity to chemical inhibitors. In the heart, PDE isozymes from at least six families have been investigated. Studies using selective PDE inhibitors and/or genetically manipulated animals have demonstrated that individual PDE isozymes play distinct roles in the heart by regulating unique cyclic nucleotide signaling microdomains. Alterations of PDE activity and/or expression have also been observed in various cardiac disease models, which may contribute to disease pro...Continue Reading

References

Dec 21, 1978·The New England Journal of Medicine·J R BenottiA A Alousi
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P F MéryR Fischmeister
Apr 1, 1991·Circulation Research·D C BodeL L Brunton
Jun 1, 1997·The Journal of Clinical Investigation·M Rivet-BastideR Fischmeister
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·S H SoderlingJ A Beavo
Sep 29, 2000·American Journal of Physiology. Heart and Circulatory Physiology·M YanoM Matsuzaki
Oct 29, 2000·Progress in Nucleic Acid Research and Molecular Biology·Y ShakurV Manganiello
Jun 5, 2001·The Journal of Physiology·G VandecasteeleR Fischmeister
Jul 4, 2001·The Journal of Physiology·M DittrichR Fischmeister
Aug 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H SenzakiD A Kass
Feb 9, 2002·Circulation Research·Sergei D RybalkinKarin E Bornfeldt
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Ramzi OckailiRakesh C Kukreja
Nov 20, 2002·Expert Opinion on Investigational Drugs·Matthew A Movsesian, Rami Alharethi
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Chen YanBradford C Berk
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·George S BaillieMiles D Houslay
Jul 2, 2003·Bioscience, Biotechnology, and Biochemistry·Noriyuki YanakaKenji Omori
Nov 12, 2003·The American Journal of Cardiology·Ralph G Brindis, Robert A Kloner
Dec 23, 2003·Current Medical Research and Opinion·Jackie CorbinSharron Francis
Feb 12, 2004·Journal of Molecular and Cellular Cardiology·Rakesh C KukrejaLei Xi
Mar 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Anindita DasRakesh C Kukreja
Jun 2, 2005·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Rodolphe FischmeisterGrégoire Vandecasteele
Jun 21, 2005·British Journal of Clinical Pharmacology·Gideon A PaulMartin R Wilkins
Sep 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Bo DingChen Yan

❮ Previous
Next ❯

Citations

Jul 9, 2011·Circulation Research·Yang K Xiang
Sep 21, 2013·Future Medicinal Chemistry·Walter Knight, Chen Yan
Oct 1, 2011·International Journal of Hypertension·William E Schutzer, Scott L Mader
Nov 4, 2011·Current Opinion in Pharmacology·Isaac LevyConstantine A Stratakis
Apr 12, 2011·Trends in Pharmacological Sciences·Manling Zhang, David A Kass
Sep 22, 2015·Journal of Molecular and Cellular Cardiology·Claire Y ZhaoRaimond L Winslow
Jul 23, 2013·Experimental Physiology·Wiebke JanssenBaktybek Kojonazarov
Feb 7, 2013·Acta Physiologica·R K Perera, V O Nikolaev
Nov 12, 2016·Scientific Reports·Fikru B BedadaJoseph M Metzger
Mar 7, 2014·Circulation Research·Konrad R GötzViacheslav O Nikolaev
Jun 2, 2012·Journal of Cardiovascular Pharmacology·Emine Demirel-YilmazMehmet Kursat Derici
Jul 30, 2017·Proteomics·Tandekile Lubelwana HafverCathrine Rein Carlson
Dec 7, 2013·Endocrine Reviews·Monalisa F AzevedoConstantine A Stratakis
Jun 19, 2013·Metallomics : Integrated Biometal Science·Lili PengShanshan Zhu
Mar 15, 2018·International Journal of Molecular Sciences·Nadja I Bork, Viacheslav O Nikolaev
Aug 10, 2012·Physiology·Dong I Lee, David A Kass
Jul 13, 2019·Canadian Journal of Physiology and Pharmacology·Esma N Okatan, Belma Turan
Nov 17, 2020·Frontiers in Cardiovascular Medicine·Namrita KaurWei Liu
Feb 27, 2021·International Journal of Biological Macromolecules·Isadora Sousa de OliveiraEliane Candiani Arantes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.